Braskem SA Class A (BAK) Stock Forecast & Price Target
Braskem SA Class A · NYSE
$2.08-0.03 (-1.18%)
15-min delayed · Sep 11, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Braskem SA Class A, 0 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a moderate sell consensus. Targets are tightly clustered, $3.80 to $3.80, so the covering firms are broadly aligned. The average target of $3.80 sits 82% above the current $2.08. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 4% next, consensus EPS building from about $-0.46 next quarter toward $-1.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Sell
Strong Buy00%
Buy00%
Hold267%
Sell133%
Strong Sell00%
Based on 3 analysts giving stock ratings to Braskem SA Class A.
As of Sep, 0 of 2 firms rate BAK a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
BAK EPS & revenue forecast
EPS · NEXT QUARTER
$-0.46
Range $-0.46 – $-0.46 · 1 analysts · -91% YoY
Next period, 1 analysts expect Braskem SA Class A to earn $-0.46 a share (range $-0.46 – $-0.46), versus $-5.33 a year earlier. Full-year consensus is $0.53, growing to $-1.08 the year after.
REVENUE · NEXT QUARTER
$17.9B
Range $17.9B – $17.9B · 1 analysts · +30% YoY
Revenue is expected to reach $17.9B (range $17.9B – $17.9B), +30.0% year-over-year. Full-year consensus is $73.7B, rising to $80.8B next year.
Top analysts covering Braskem SA Class A
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BAK.
#1
TV
Tasso Vasconcellos
UBS
Hold
$3.80+82.3% to target
Coverage
—
+ Follow
#2
GB
Gabriel Barra
Citigroup
Sell
No targeton BAK
Coverage
—
+ Follow
#3
RR
Ricardo Rezende
JP Morgan
Hold
$5.00+139.8% to target
Coverage
—
+ Follow
#4
LC
Luiz Carvalho
UBS
Buy
$10.00+379.6% to target
Coverage
—
+ Follow
BAK stock forecast FAQ
What is BAK's average 12-month price target?+
The 1 analysts with a live target average $3.80 for Braskem SA Class A over the next 12 months, ranging from a $3.80 high to a $3.80 low.
Is BAK stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Sell. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
How many Wall Street analysts cover BAK?+
3 analysts have an active rating on Braskem SA Class A, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering BAK?+
Among analysts who currently cover BAK, Tasso Vasconcellos of UBS has the strongest overall Quantellect track record. Their current call is Hold with a $3.80 target.
What is Braskem SA Class A's projected EPS for next quarter?+
The consensus estimate is $-0.46 per share (range $-0.46 – $-0.46) across 1 analysts. Full-year EPS is projected at $0.53, rising to $-1.08 the following year.
How much revenue is Braskem SA Class A expected to report next quarter?+
Consensus revenue is $17.9B (range $17.9B – $17.9B). Full-year revenue is projected at $73.7B, growing to $80.8B next year.
Have analysts been upgrading or downgrading BAK lately?+
As of Sep, 0 of 2 firms rate BAK a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BAK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
JP Morgan
